Impact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
Author
Amar, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Vithayathil, Mathew; et al
Date
2022
Citation:
APA:
Amar, Suneetha, & Muzaffar, Mahvish, & Naqash, Abdul Rafeh, & Vithayathil, Mathew, & et al. (January 2022).
Impact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular Carcinoma.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/12345
MLA:
Amar, Suneetha, and Muzaffar, Mahvish, and Naqash, Abdul Rafeh, and Vithayathil, Mathew, and et al.
"Impact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular Carcinoma". .
. (),
January 2022.
May 01, 2024.
http://hdl.handle.net/10342/12345.
Chicago:
Amar, Suneetha and Muzaffar, Mahvish and Naqash, Abdul Rafeh and Vithayathil, Mathew and et al,
"Impact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular Carcinoma," , no.
(January 2022),
http://hdl.handle.net/10342/12345 (accessed
May 01, 2024).
AMA:
Amar, Suneetha, Muzaffar, Mahvish, Naqash, Abdul Rafeh, Vithayathil, Mathew, et al.
Impact of Older Age in Patients Receiving Atezolizumab and Bevacizumab for Hepatocellular Carcinoma. .
January 2022;
():
.
http://hdl.handle.net/10342/12345. Accessed
May 01, 2024.
Collections